Sana Biotechnology annual current ratio
2020
2021
2022
2023
2024
2025
Sana Biotechnology Current Ratio Growth & History (SANA)
Sana Biotechnology's current ratio was 1.89 for fiscal 2025.
View full Sana Biotechnology company overviewSana Biotechnology annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.89 | −1.65 | −46.64% |
| 2024 | 2024-12-31 | 3.54 | 0.23 | +6.90% |
| 2023 | 2023-12-31 | 3.31 | −0.67 | −16.93% |
| 2022 | 2022-12-31 | 3.99 | −1.64 | −29.13% |
| 2021 | 2021-12-31 | 5.62 | −6.60 | −53.99% |
| 2020 | 2020-12-31 | 12.22 | — | — |
Sana Biotechnology quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.38 | −1.09 | −44.11% |
| Q1 2026 | 2026-03-31 | 1.29 | −2.11 | −61.92% |
| Q4 2025 | 2025-12-31 | 1.89 | −1.65 | −46.64% |
| Q3 2025 | 2025-09-30 | 4.55 | 0.08 | +1.88% |
| Q2 2025 | 2025-06-30 | 2.47 | −2.73 | −52.54% |
| Q1 2025 | 2025-03-31 | 3.40 | −2.67 | −44.01% |
| Q4 2024 | 2024-12-31 | 3.54 | 0.23 | +6.90% |
| Q3 2024 | 2024-09-30 | 4.47 | 0.28 | +6.60% |
| Q2 2024 | 2024-06-30 | 5.20 | 2.18 | +72.07% |
| Q1 2024 | 2024-03-31 | 6.07 | 2.47 | +68.73% |
| Q4 2023 | 2023-12-31 | 3.31 | −0.67 | −16.93% |
| Q3 2023 | 2023-09-30 | 4.19 | −0.16 | −3.74% |
| Q2 2023 | 2023-06-30 | 3.02 | −2.07 | −40.67% |
| Q1 2023 | 2023-03-31 | 3.60 | −2.00 | −35.68% |
| Q4 2022 | 2022-12-31 | 3.99 | −1.64 | −29.13% |
| Q3 2022 | 2022-09-30 | 4.36 | −2.30 | −34.58% |
| Q2 2022 | 2022-06-30 | 5.09 | −15.00 | −74.65% |
| Q1 2022 | 2022-03-31 | 5.60 | −21.93 | −79.67% |
| Q4 2021 | 2021-12-31 | 5.62 | −6.60 | −53.99% |
| Q3 2021 | 2021-09-30 | 6.66 | — | — |
| Q2 2021 | 2021-06-30 | 20.09 | — | — |
| Q1 2021 | 2021-03-31 | 27.52 | — | — |
| Q4 2020 | 2020-12-31 | 12.22 | — | — |
Sana Biotechnology current ratio trends
Over the last five fiscal years, Sana Biotechnology's current ratio decreased from 12.22 to 1.89, a change of −10.34. The latest reported quarter, Q2 2026, shows 1.38.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sana Biotechnology source filings ↗